Bedaquiline fumarate

TypeName: Business Offer
Category:
Offer Date:2019/06/10
Country: United States
Summary: Bedaquiline fumarate is an anti-tuberculosis drug which selectively inhibits the mycobacterial energy metabolism and found to be effective against all states of Mycobacterium tuberculosis. It possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase. It has an excellent in vitro activity against Mycobacterium tuberculosis, including multidrug resistant M tuberculosis, however, its side effect profile limits its use against MDR-TB when no other effective regimen can be provided. https://www.bocsci.com/bedaquiline-fumarate-cas-845533-86-0-item-463644.html
Description:
OfferId: 4503
Name:Alex Brown
Telphone:
Categories